Ebstein’s anomaly is a rare heart defect in which parts of the tricuspid valve are abnormal. Our surgical team has pioneered the best treatments for this defect, and has published extensive research on the condition. The graph above shows that from January 2015 to December 2018, children treated at Le Bonheur had an 83.3 percent survival rate.
Why this is important: Le Bonheur’s Heart Institute measures quality using data compiled by the Society of Thoracic Surgeons, or STS. STS gathers data from other top pediatric heart programs in the country, and publishes that information twice a year. This information helps us benchmark ourselves among other top pediatric heart programs.
